# Comprehensive ADR Reporting & Documentation System

**A structured educational framework for adverse drug reaction (ADR) documentation, seriousness assessment, clinical management and pharmacovigilance reporting.**

![Domain](https://img.shields.io/badge/Domain-Pharmacovigilance-blue)
![Focus](https://img.shields.io/badge/Focus-Drug%20Safety-green)
![Type](https://img.shields.io/badge/Type-Educational%20Project-purple)

## 1. Project overview
Accurate ADR reporting requires a clear, chronological and sufficiently complete record of the patient, suspected reaction, medicinal products, clinical context, management, seriousness, outcome and reporter. This repository converts an educational checklist into a practical documentation workflow.

This is an educational framework. It is not validated reporting software and does not replace official national reporting forms, institutional SOPs, clinical judgement or applicable regulatory requirements.

## 2. Objectives
- Organise essential patient and reaction information.
- Record suspected and concomitant medicinal products.
- Document clinical context, laboratory findings and relevant history.
- Capture management, dechallenge and any already-available rechallenge information.
- Distinguish reaction severity from regulatory seriousness.
- Record outcome, reporter information and causality assessment.
- Improve completeness and traceability of safety case documentation.

## 3. Project modules
| Module | Subject | Main output |
|---|---|---|
| 01 | Patient information | Confidential patient profile |
| 02 | Reaction details | Reaction description and timeline |
| 03 | Medication data | Suspected/concomitant drug record |
| 04 | Clinical context | History, tests and co-medications |
| 05 | Management | Actions, dechallenge/rechallenge |
| 06 | Seriousness and outcome | Regulatory seriousness and outcome |
| 07 | Reporter information | Reporter and report metadata |
| 08 | Causality | WHO–UMC assessment record |
| 09 | Quality review | Completeness check before submission |

## 4. Reporting workflow
1. Receive and log the suspected safety report.
2. Establish an appropriately identifiable patient record while protecting privacy.
3. Describe the event and record onset/recovery dates where known.
4. Identify suspected, interacting and concomitant products.
5. Capture medical history, allergies, tests and relevant clinical context.
6. Record treatment changes and clinical management.
7. Assess seriousness using applicable criteria.
8. Record the patient's latest known outcome.
9. Document reporter details through the authorised reporting channel.
10. Perform and document causality assessment.
11. Identify missing information and request follow-up where appropriate.
12. Submit through the relevant institutional or regulatory pathway and retain an audit trail.

## 5. Repository contents
- [Patient information](docs/patient-information.md)
- [Reaction documentation](docs/reaction-documentation.md)
- [Medication history](docs/medication-history.md)
- [Clinical management and context](docs/clinical-management.md)
- [Seriousness and outcome](docs/seriousness-and-outcome.md)
- [Reporter information](docs/reporter-information.md)
- [Reusable ADR report template](templates/adr-report-template.md)
- [Illustrative fictional case](case-studies/illustrative-case.md)
- [References](REFERENCES.md)

## 6. Minimum ICSR elements
An ICSR generally requires four minimum elements for a valid individual case:
1. An identifiable patient.
2. An identifiable reporter.
3. At least one suspected or interacting medicinal product.
4. At least one adverse event/reaction or other relevant safety observation.

These minimum validity elements do not mean the report is complete. Follow the applicable regional requirements and current ICH guidance.

## 7. Important distinctions
- **Severity** describes intensity; **seriousness** is determined by regulatory outcome-based criteria.
- A temporal association alone does not prove causality.
- Dechallenge/rechallenge information should be recorded when available; do not intentionally rechallenge a patient solely to confirm causality if it could cause harm.
- Unknown information should be marked unknown/not available, never guessed.
- Reporter and patient identifiers belong only in protected reporting systems, not in public example files.

## 8. Learning outcomes
Learners should be able to structure an ADR report, document medicine exposure and event chronology, recognise seriousness criteria, record outcomes, protect confidentiality and understand the role of causality assessment.

## 9. Disclaimer
This repository contains educational material and a fictional example only. It contains no real patient data and does not represent an actual regulatory submission.

**Project domain:** Pharmaceutical Sciences  
**Focus:** Pharmacovigilance, ADR reporting, ICSR documentation and patient safety  
**Project author:** Shozaf Qureshi
